Chunmeng Shi Selected Research

2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindolium

1/2022	Effects of Human Serum Albumin on the Fluorescence Intensity and Tumor Imaging Properties of IR-780 Dye.
10/2021	Pharmaceutical targeting of succinate dehydrogenase in fibroblasts controls bleomycin-induced lung fibrosis.
1/2021	Mitigation of radiation-induced pulmonary fibrosis by small-molecule dye IR-780.
1/2019	Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor.
1/2019	Fibrogenic fibroblast-selective near-infrared phototherapy to control scarring.
4/2014	Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells.
1/2014	Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent.
3/2012	A NIR heptamethine dye with intrinsic cancer targeting, imaging and photosensitizing properties.
9/2010	A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunmeng Shi Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 01/2008
12	Wounds and Injuries (Trauma) 01/2020 - 01/2003
7	Fibrosis (Cirrhosis) 01/2022 - 04/2015
6	Neoplasm Metastasis (Metastasis) 10/2020 - 05/2010
5	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2016
3	Ulcer 01/2020 - 01/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 08/2008
2	Disease Progression 01/2021 - 09/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 10/2020
2	Glaucoma 01/2020 - 01/2020
2	Cicatrix (Scar) 01/2020 - 01/2019
2	Carcinogenesis 08/2017 - 11/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2010 - 11/2010
1	Nausea 01/2022
1	Vomiting 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Diarrhea 01/2022
1	Triple Negative Breast Neoplasms 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Fatty Liver 01/2021
1	Acute Lung Injury 01/2021
1	Radiodermatitis 01/2021
1	Leukemia 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Malaria 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Obesity 01/2021
1	Insulin Resistance 01/2021
1	Liver Neoplasms (Liver Cancer) 10/2020
1	COVID-19 09/2020
1	Blister (Bulla) 01/2020
1	Adenocarcinoma 01/2020
1	Skin Ulcer 10/2019

Drug/Important Bio-Agent (IBA)

13	Coloring Agents (Dyes)IBA 01/2022 - 05/2010
9	2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA 01/2022 - 09/2010
9	Pharmaceutical PreparationsIBA 10/2021 - 01/2008
7	Peptides (Polypeptides)IBA 01/2018 - 05/2010
5	Therapeutic UsesIBA 01/2021 - 07/2004
5	Biological ProductsIBA 01/2020 - 10/2011
5	Contrast MediaIBA 11/2017 - 03/2013
5	LigandsIBA 01/2016 - 08/2008
4	Fluorescent Dyes (Fluorescent Probes)IBA 02/2012 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2009
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2011
3	Organic Anion TransportersIBA 01/2018 - 09/2010
3	AnionsIBA 11/2017 - 05/2010
2	AlbuminsIBA 01/2022 - 11/2017
2	Human Serum Albumin FDA LinkGeneric 01/2022 - 11/2017
2	AntioxidantsIBA 01/2020 - 01/2019
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2019 - 08/2017
2	AntigensIBA 01/2019 - 08/2009
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2017 - 07/2016
2	MicroRNAs (MicroRNA)IBA 11/2015 - 12/2012
2	IodidesIBA 01/2014 - 09/2010
2	CollagenIBA 12/2012 - 01/2003
2	AntibodiesIBA 10/2011 - 01/2009
2	heptamethine cyanine dyeIBA 09/2010 - 05/2010
2	Sulfobromophthalein (Sulfobromophthalein Sodium)IBA 09/2010 - 05/2010
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2004 - 10/2003
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 06/2004 - 10/2003
1	Serum AlbuminIBA 01/2022
1	Radiation-Protective Agents (Radiation Protectants)IBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021
1	Succinic Acid (Succinate)IBA 10/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 10/2021
1	Cathepsin FIBA 01/2021
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2021
1	artemisinin (artemisinine)IBA 01/2021
1	IronIBA 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	ArtesunateIBA 01/2021
1	Liver X ReceptorsIBA 10/2020
1	Long Noncoding RNAIBA 10/2020
1	Oxygen (Dioxygen)IBA 09/2020
1	Antiviral Agents (Antivirals)IBA 09/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	Ophthalmic Solutions (Eye Drops)IBA 01/2020
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2020
1	cordycepinIBA 10/2019
1	NucleosidesIBA 10/2019
1	AldehydesIBA 08/2019
1	HydrogelsIBA 08/2019
1	Sulfhydryl Compounds (Thiols)IBA 08/2019
1	QuercetinIBA 01/2019
1	AndrogensIBA 01/2019

Therapy/Procedure

18	Therapeutics 10/2021 - 01/2006
8	Precision Medicine 07/2018 - 02/2012
7	Radiotherapy 01/2022 - 04/2016
4	Transplantation 01/2019 - 01/2003
4	Quantum Dots (Quantum Dot) 12/2010 - 01/2008
2	Filtering Surgery 01/2020 - 01/2020
2	Phototherapy (Light Therapy) 01/2019 - 07/2016
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2016
2	Photochemotherapy (Photodynamic Therapy) 07/2016 - 03/2012
2	Intravenous Injections 07/2016 - 08/2009
1	Surgical Amputation (Amputations) 01/2020
1	Adjuvant Radiotherapy 01/2020